HalioDx

Veracyte is a global diagnostics firm that helps patients get better care by answering critical clinical questions that help doctors make better diagnoses and treatment decisions throughout their cancer and other disease journeys. In the era of immuno-oncology and combination therapies, our immuno-oncology diagnostic technologies and services – formerly HalioDx – assist guide cancer therapy and contribute to precision medicine.
The company offers a unique spectrum of immune scoring solutions, including the Immunoscore® assay for analysing the immunological contexture of a tumour, based on Dr. Jérôme Galon's pioneering work.
Immunoscore® in colon cancer is a CLIA or CE-marked test that can help oncologists make better decisions on a daily basis. Immunoscore® could be used to diagnose other cancers, as immune response to tumours is a critical indicator of disease progression.